Srini Akkaraju is the Founder and Managing General Partner of Samsara BioCapital, a biotech investment firm focused on translating cutting-edge biology into new therapies. His career includes leadership roles at Sofinnova Ventures, New Leaf Venture Partners, and Genentech. He holds an MD and a PhD in Immunology from Stanford University.
He has a unique educational foundation, holding dual undergraduate degrees in Biochemistry and Computer Science from Rice University.
Srini Akkaraju
Managing General Partner at Samsara BioCapital
Burlingame, California, United States
Overview
Topics They Care About
Biotech Innovation
He believes the industry is in an "unbelievable innovation cycle" and is focused on funding transformative therapies for unmet medical needs, particularly in epigenetics and mitochondrial biology.
Drug Development
His investment philosophy centers on guiding companies through the entire risk cycle, from private funding to public markets, with a focus on building new therapeutics.
Corporate Governance
He has extensive experience serving as a director on the boards of numerous public and private biotech companies, including Scholar Rock, Syros Pharmaceuticals, and Mineralys Therapeutics.
Media Appearances
Srini has no verified media appearances
Work History
Managing General Partner at Samsara BioCapital
4-2013
General Partner at Sofinnova Ventures
1-2009 - 4-2013
Managing Director at New Leaf Venture Partners
4-2006 - 12-2008
Managing Director at Panorama Capital
4-2001
Associate, Principal, Partner at JPMP
Education
1990 - 1998
MD from Stanford University
1990 - 1998
MD from Stanford University School of Medicine
More Information
Social Presence :
Prographics :
Exp : 24
Location : Burlingame, California, United States
Job Level : Senior
Designation : Managing General Partner at Samsara BioCapital
